UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 221

Sortiert nach

Cysteine thiol sulfinic acid in plant stress signaling

Plant, cell and environment, 2024-08, Vol.47 (8), p.2766-2779

2024

Volltextzugriff (PDF)

Fueling CARs: metabolic strategies to enhance CAR T-cell therapy

Experimental hematology & oncology, 2024-07, Vol.13 (1), p.66-17, Article 66

2024

Volltextzugriff (PDF)

Targeting mTOR signaling pathways in multiple myeloma: biology and implication for therapy

Cell communication and signaling, 2024-06, Vol.22 (1), p.1-320, Article 320

2024

Volltextzugriff (PDF)

Should Developed Economies Manage International Capital Flows? An Empirical and Welfare Analysis

Oxford bulletin of economics and statistics, 2024-06

2024

Volltextzugriff (PDF)

Anti-Idiotypic VHHs and VHH-CAR-T Cells to Tackle Multiple Myeloma: Different Applications Call for Different Antigen-Binding Moieties

International journal of molecular sciences, 2024-06, Vol.25 (11), p.5634

2024

Volltextzugriff (PDF)

Scrutiny of chimeric antigen receptor activation by the extracellular domain: experience with single domain antibodies targeting multiple myeloma cells highlights the need for case-by-case optimization

Frontiers in immunology, 2024-04, Vol.15, p.1389018-1389018

2024

Volltextzugriff (PDF)

AXL-specific single domain antibodies show diagnostic potential and anti-tumor activity in Acute Myeloid Leukemia

Theranostics, 2024-01, Vol.14 (7), p.2656-2674

2024

Volltextzugriff (PDF)

S-adenosylmethionine biosynthesis is a targetable metabolic vulnerability in multiple myeloma

Haematologica (Roma), 2024-01, Vol.109 (1), p.256

2024

Volltextzugriff (PDF)

Targeting S100A9 protein affects mTOR-ER stress signaling and increases venetoclax sensitivity in Acute Myeloid Leukemia

Blood cancer journal (New York), 2023-12, Vol.13 (1), p.188-188, Article 188

2023

Volltextzugriff (PDF)

The effect of psychological factors on pain outcomes: lessons learned for the next generation of research

Pain reports, 2023-12, Vol.8 (6), p.e1112-e1112

2023

Volltextzugriff (PDF)

EU legal proposal for genome-edited crops hints at a science-based approach

Trends in plant science, 2023-12, Vol.28 (12), p.1350-1353

2023

Volltextzugriff (PDF)

RNA-sequencing based first choice of treatment and determination of risk in multiple myeloma

Frontiers in immunology, 2023-11, Vol.14, p.1286700-1286700

2023

Volltextzugriff (PDF)

P-300 Targeting DNMT3B impairs multiple myeloma cell proliferation and clonogenic capacity and enhances sensitivity to standard of care agents

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S203-S203

2023

Volltextzugriff (PDF)

P-409 Elevated LAG-3 expression in plasma cells and lymphoid subpopulations at distinct stages of multiple myeloma disease progression

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S266-S267

2023

Volltextzugriff (PDF)

P-402 Inhibition of proline production by stromal cells negatively impacts myeloma tumor growth by reducing cytokine and growth factor secretion

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S262-S263

2023

Volltextzugriff (PDF)

Improvement of silicon heterojunction module efficiency using fast illumination post-treatments

Solar energy materials and solar cells, 2023-08, Vol.257, p.112395, Article 112395

2023

Volltextzugriff (PDF)

Metformin confers sensitisation to syrosingopine in multiple myeloma cells by metabolic blockage and inhibition of protein synthesis

The Journal of pathology, 2023-06, Vol.260 (2), p.112-123

2023

Volltextzugriff (PDF)

Targeting stromal cell sialylation reverses T cell-mediated immunosuppression in the tumor microenvironment

Cell reports (Cambridge), 2023-05, Vol.42 (5), p.112475-112475, Article 112475

2023

Volltextzugriff (PDF)

Targeted α-Therapy Using 225Ac Radiolabeled Single-Domain Antibodies Induces Antigen-Specific Immune Responses and Instills Immunomodulation Both Systemically and at the Tumor Microenvironment

The Journal of nuclear medicine (1978), 2023-05, Vol.64 (5), p.751-758

2023

Volltextzugriff (PDF)

Targeted α-Therapy Using 225 Ac Radiolabeled Single-Domain Antibodies Induces Antigen-Specific Immune Responses and Instills Immunomodulation Both Systemically and at the Tumor Microenvironment

Journal of Nuclear Medicine, 2023-05, Vol.64 (5), p.751-758

2023

Volltextzugriff (PDF)

Abstract 2505: PYCR1 inhibition in multiple myeloma-associated stroma limits tumor growth

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.2505-2505

2023

Volltextzugriff (PDF)

Reduction in Indium Usage for Silicon Heterojunction Solar Cells in a Short‐Term Industrial Perspective

Solar RRL, 2023-04, Vol.7 (8), p.n/a

2023

Volltextzugriff (PDF)

Targeting the β2‐adrenergic receptor increases chemosensitivity in multiple myeloma by induction of apoptosis and modulating cancer cell metabolism

The Journal of pathology, 2023-01, Vol.259 (1), p.69-80

2023

Volltextzugriff (PDF)

Targeting the β 2 -adrenergic receptor increases chemosensitivity in multiple myeloma by induction of apoptosis and modulating cancer cell metabolism

The Journal of pathology, 2023-01, Vol.259 (1), p.69-80

2023

Volltextzugriff (PDF)

Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myeloma

Journal for immunotherapy of cancer, 2023-01, Vol.11 (1), p.e005319

2023

Volltextzugriff (PDF)

1 – 25 von 221

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(168)
Mit Volltextzugriff
(202)

Publikationsform

Sprache

Englisch
(218)
Japanisch
(24)
Deutsch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(105)
Life Sciences & Biomedicine
(58)
Multiple Myeloma
(45)
Humans
(39)
Physics
(38)
Physical Sciences
(37)
Technology
(36)
Oncology
(35)
Materials Science
(27)
Animals
(26)
Materials Science, Multidisciplinary
(25)
Physics, Applied
(23)
Exact Sciences And Technology
(22)
Mice
(21)
Hematology
(20)
Multiple Myeloma - Pathology
(19)
Social Sciences
(18)
Physics, Condensed Matter
(16)
Apoptosis
(14)
Condensed Matter: Structure, Mechanical And Thermal Properties
(14)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Cysteine thiol sulfinic acid in plant stress signaling

Fueling CARs: metabolic strategies to enhance CAR T-cell therapy

Targeting mTOR signaling pathways in multiple myeloma: biology and implication for therapy

Should Developed Economies Manage International Capital Flows? An Empirical and Welfare Analysis

Anti-Idiotypic VHHs and VHH-CAR-T Cells to Tackle Multiple Myeloma: Different Applications Call for Different Antigen-Binding Moieties

Scrutiny of chimeric antigen receptor activation by the extracellular domain: experience with single domain antibodies targeting multiple myeloma cells highlights the need for case-by-case optimization

AXL-specific single domain antibodies show diagnostic potential and anti-tumor activity in Acute Myeloid Leukemia

S-adenosylmethionine biosynthesis is a targetable metabolic vulnerability in multiple myeloma

Targeting S100A9 protein affects mTOR-ER stress signaling and increases venetoclax sensitivity in Acute Myeloid Leukemia

The effect of psychological factors on pain outcomes: lessons learned for the next generation of research

EU legal proposal for genome-edited crops hints at a science-based approach

RNA-sequencing based first choice of treatment and determination of risk in multiple myeloma

P-300 Targeting DNMT3B impairs multiple myeloma cell proliferation and clonogenic capacity and enhances sensitivity to standard of care agents

P-409 Elevated LAG-3 expression in plasma cells and lymphoid subpopulations at distinct stages of multiple myeloma disease progression

P-402 Inhibition of proline production by stromal cells negatively impacts myeloma tumor growth by reducing cytokine and growth factor secretion

Improvement of silicon heterojunction module efficiency using fast illumination post-treatments

Metformin confers sensitisation to syrosingopine in multiple myeloma cells by metabolic blockage and inhibition of protein synthesis

Targeting stromal cell sialylation reverses T cell-mediated immunosuppression in the tumor microenvironment

Targeted α-Therapy Using 225Ac Radiolabeled Single-Domain Antibodies Induces Antigen-Specific Immune Responses and Instills Immunomodulation Both Systemically and at the Tumor Microenvironment

Targeted α-Therapy Using 225 Ac Radiolabeled Single-Domain Antibodies Induces Antigen-Specific Immune Responses and Instills Immunomodulation Both Systemically and at the Tumor Microenvironment

Abstract 2505: PYCR1 inhibition in multiple myeloma-associated stroma limits tumor growth

Reduction in Indium Usage for Silicon Heterojunction Solar Cells in a Short‐Term Industrial Perspective

Targeting the β2‐adrenergic receptor increases chemosensitivity in multiple myeloma by induction of apoptosis and modulating cancer cell metabolism

Targeting the β 2 -adrenergic receptor increases chemosensitivity in multiple myeloma by induction of apoptosis and modulating cancer cell metabolism

Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myeloma

Suchergebnisse filtern